S2 E2.2 Economic and Patient Motivation Costs and Value of telemedicine and New Non-Invasive Diagnostic Testing

Evaluating the economic and patient-motivating value of enhanced telemedicine and mobile non-invasive testing technologies in improving NAFLD diagnosis and lowering rates of non-communicable disease

The Surfers and our guest Dr. Manal Abdelmalek consider the economic costs and value of enhanced telemedicine and mobile “de-liver” testing technology, and then move on to consider critical success factors in making these innovations patient friendly and motivating patients to take advantage of them.

Full Episode

Season 2 Episode 2

The NASH Tsunami In Diabetes

Categories for NASH Tsunami
AASLD Allied Health Professionals Cirrhosis Clinical Trials Companies COVID-19 Diabetes Diagnostics Doctors Drugs/Drug Classes Drug therapies Endocrinology clinics Epidemiology Fatty Liver FDA FIB-4 GLP-1s Guidelines Hepatology Histopathology Inside The Vault Investors Liver Science Major Meetings Metabolic Diseases Motivating front-line treaters NAFLD NAFLD Prevalence NAIL-NIT NASH NASH-TAG NASH/Diabetes Co-Morbidity NITs Obesity Patient Advocacy Patients Pediatric NASH Podcast Prevalence/Incidence Public Health Rising Tide Science Special Subpopulations Suggested Reading Type 2 Diabetes Mellitus

Listen Now

Apple Spotify Youtube
Copyright © SurfingNASH.Com 2020—2023
Linkedin Facebook Twitter Instagram
Stay In Touch
Apple Spotify Youtube